Syncom Formulations (India)

Syncom Formulations (India) Limited is a pharmaceutical company primarily focused on the manufacturing, marketing, and sale of pharmaceutical formulations within India. Their operations are structured across three key segments: manufacturing and dealing in pharmaceutical drugs and formulations, trading of commodities, and renting of properties. The core of their business lies in the production and distribution of a wide array of pharmaceutical products.

Their pharmaceutical product portfolio is extensive and covers various therapeutic areas. This includes antibiotics and anti-infectives to combat bacterial infections, anthelmintics for parasitic worm infestations, antimalarial drugs for malaria treatment, and medications targeting cardiac (heart-related) conditions. Beyond these, they offer formulations for dermatological (skin), gastrointestinal, gynecological, ophthalmological (eye), orthopedic, and pediatric applications. This broad range of offerings demonstrates a commitment to providing solutions across a diverse spectrum of healthcare needs.

In addition to their core pharmaceutical offerings, Syncom Formulations also markets and distributes a line of health and wellness products under the Cratus brand. These products, categorized as life care, evolve, and right nutrition products, likely represent an effort to expand their reach beyond prescription medications and cater to a broader consumer base interested in preventative healthcare and supplementary nutrition. This diversification strategy allows them to engage a wider segment of the market.

The company’s operational scope extends beyond pharmaceutical manufacturing and sales. They actively engage in the trading of commodities, suggesting involvement in the procurement of raw materials and potentially other related goods. Further, the renting of properties indicates a supplementary income stream, possibly through the ownership of facilities used in their operations or through independent real estate holdings. This diversification mitigates risk and provides additional revenue streams.

Syncom Formulations distributes its products in various dosage forms, showcasing a commitment to offering flexible and convenient treatment options for patients. These forms include tablets, capsules, ointments, injections, oral liquids, and effervescent formulations, reflecting adaptability to the needs of different medical conditions and patient preferences. The company also exports its products, demonstrating a presence in international markets beyond India’s borders.